![Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-021-00592-1/MediaObjects/41577_2021_592_Fig1_HTML.png)
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice | PLOS ONE
![Comparison of vaccine potency measured by SRID and VaxArray HA. (A)... | Download Scientific Diagram Comparison of vaccine potency measured by SRID and VaxArray HA. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/324707000/figure/fig4/AS:619791542927362@1524781227582/Comparison-of-vaccine-potency-measured-by-SRID-and-VaxArray-HA-A-shows-the-correlation.png)
Comparison of vaccine potency measured by SRID and VaxArray HA. (A)... | Download Scientific Diagram
![Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 - ScienceDirect Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379122001598-fx1.jpg)
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 - ScienceDirect
Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines | ACS Infectious Diseases
![Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants - ScienceDirect Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666634022000897-fx1.jpg)
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants - ScienceDirect
![Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS](https://www.pnas.org/cms/10.1073/pnas.2206333119/asset/236fdffd-523f-4be1-9eaa-7281bdb57fbd/assets/images/large/pnas.2206333119fig01.jpg)
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS
![Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants | mBio Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants | mBio](https://journals.asm.org/cms/10.1128/mBio.02656-21/asset/8b9c6aa3-9cf5-4a42-9dfb-1c42ef91a328/assets/images/medium/mbio.02656-21-f001.gif)